My Watchlist
Subscribe and get alerts for the stocks and topics you follow
|
|
Healthcare
Add to Watchlist
|
|
Dillard’s Inc. (NYSE: DDS) rose as high as over 10% to a yearly high of $15.79 after the department-store chain was upgraded by Deutsche Bank AG.
Dress Barn Inc. (NASDAQ: DBRN) rose as high as 9.2% to a yearly his of $22.42 after the women’s clothing retailer announced earnings of $0.37, beating a...
|
|
|
straightstocks.com
-
Nov 20, 2009
about
MS, FC, CRL
Biogen Idec (BIIB) and Genentech, Inc., a wholly-owned member of the Roche Group (RHHBY.PK), announced that they have received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for Rituxan. The companies were seeking approval for the use of Rituxan (rituximab) plus f...
|
|
|
straightstocks.com
-
Nov 20, 2009
about
AMGN, IMGN, TAP
ImmunoGen, Inc. (NASDAQ:IMGN) has announced that Amgen, Inc. (NASDAQ:AMGN)Inc has licensed the exclusive right to use ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology for the development of anticancer therapeutics to an undisclosed ...
|
|
|
straightstocks.com
-
Nov 20, 2009
about
CRXX
Neuromed and CombinatoRx, Incorporated (NASDAQ:CRXX)has agreed to sign a definitive merger agreement valued $28.8 million USD on 30th June, 2009 according to a news published by the RTT News.
Although the “merger” declaration with privately ...
|
|
|
straightstocks.com
-
Nov 20, 2009
about
SCMP
Sucampo Pharma Europe Ltd, a subsidiary of Sucampo Pharmaceuticals Inc (NASDAQ:SCMP) has announced that Swissmedic has granted a marketing authorization for Amitiza 24 mcg gel capsules for the long term treatment of ...
|
|
|
These are this morning’s top day trader alerts and active trader alerts early this Friday morning. We have links through to each stock at VSInvestor.com with more data and analysis on each:
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) down almost 6% on its secondary offering.
Dell Inc. (NASDAQ: DE...
|
|
|
minyanville.com
-
Nov 19, 2009
about
ACS, AZN
The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before generic medications flood the market. AstraZeneca (AZN) announced Thursday morning that it has filed a...
|
|
|
researchrecap.com
-
Nov 19, 2009
about
LLY, BMY, PFE
Increasing exposure to patent expiries and downward trends in pipeline quality continue to underpin Moody’s negative outlook for the industry, though the outlook for generics is more positive.
Excerpts from Moody’s latest Global Pharmaceuticals Firms Industry Outlook:
Companies have taken measures...
|
|
|
The More Focused, and More Opaque, Buffett & Berkshire Hathaway (BRK-A, BRK-B, BNI, UNP, NSC, GS, GE, TIF, HOG, WMT, COP, XOM, WFC, RSG, DOW, ETN, WBC, MCO, WLP, UNH, GSK, SNY, GCI, WPO)
247wallst.com
-
Nov 19, 2009
about
WPO, XOM, HOG and 19 moreDOW, GS, UNP, GCI, WBC, MCO, UNH, COP, WLP, RSG, TIF, BNI, SNY, WMT, GE, NSC, GSK, ETN, WFC
This was an important week for investment guru and billionaire watchers to see which gurus were holding which stocks. The full public equity holdings of Warren Buffett via Berkshire Hathaway Inc. (NYSE: BRK-A) were particularly of note, particularly with those B shares under “BRK-B” soon to split a...
|
|
|
These are this morning’s top day trader alerts and active trader alerts in stocks early on Thursday. We have more details and analysis over at VSInvestor.com for each stock:
Intel Corporation (NASDAQ: INTC) is down 3% on the downgrade from BofAML.
Hot Topic, Inc. (NASDAQ: HOTT) is down sharply on e...
|
|
|
straightstocks.com
-
Nov 19, 2009
about
MDCO
The Medicines Company's (MDCO) third-quarter loss per share of 6 cents missed the Zacks Consensus Estimate of a loss of 5 cents. Although Angiomax continues to contribute significantly to revenues, we are concerned about the product losing exclusivity in the U.S. in September 2010.
The entry of gen...
|
|
|
minyanville.com
-
Nov 18, 2009
about
VVUS, LLY, PFE
Vivus (VVUS) is raising the bar on erectile dysfunction drugs potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based pharmaceutical company jumped on Wednesday when the company cited positive results from a late-stage...
|
|
|
researchrecap.com
-
Nov 18, 2009
about
BMY, KFT, HSY
Analysts are mostly skeptical about the likelihood of Hershey (HSY) and Ferrero mounting a successful joint bid for Cadbury (CBRY) to thwart Kraft’s (KFT) pending bid for the company. However, the threat of a rival bid may be enough to coax a slightly sweeter offer from Kraft.
Both Bloomberg and Reu...
|
|
|
businessinsider.com
-
Nov 18, 2009
about
MTXX
The mysterious Ukrainian mutant flu we reported on earlier is now in full swing as eastern Europe buckles down for its potential spread into neighboring countries.
Over 1.4 million people are now infected, with the number spreading rapidly. 12 people have died in the past 24 hours even.
Ria: The dea...
|
|
|
Below is a guest post, reprinted with permission of author Vitaliy Katsenelson who writes often at Minyanville.com. I don't have as much time to read the site as I used to, but he is definitely one of the more thought provoking writers at the site.
If you are new to FMMF, I wanted to bring over V...
|
|
|
straightstocks.com
-
Nov 18, 2009
about
EXEL
Exelixis, Inc (NASDAQ:EXEL) has announced and reported that the interim data from an ongoing Phase 1 dose-escalation trial of XL147 (SAR245408) in combination with paclitaxel and carboplatin in patients with advanced solid ...
|
|
|
straightstocks.com
-
Nov 18, 2009
about
IMGN
ImmunoGen, Inc (NASDAQ:IMGN) have reported the clinical data of their IMGN901 product candidate which will be used for the treatment of Merkel cell carcinoma (MCC).
The Company mentioned that the meaningful evidence of ...
|
|
|
These are this morning’s top day trader and active trader alerts with big volume or big moves in early pre-market trading. We have more detailed analysis and data with a link to each stock at VSInvestor.com:
Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is recovering again.
Netlist Inc. (NASDAQ: NLS...
|
|
|
Top 10 Analyst Upgrades, Downgrades, Initiations (ADI, ACI, ISRG, BTU, PHM, RIMM, STX, SPWRA, TGT, WDC)
These are this Wednesday’s top ten analyst upgrades, downgrades, and initiations seen in Wall Street research calls:
Analog Devices (NYSE: ADI) Raised to Conviction Buy List at Goldman Sachs.
Arch Coal (NYSE: ACI) Started as Overweight at HSBC.
Intuitive Surgical (NASDAQ: ISRG) Started as Market Per...
|
|
|
Great investors have goals and strategies are only the tools that help them accomplish their targets. My goal is to generate a rising stream of dividend income, which would allow me to leave the rat race and spend my time doing worthwhile things like education and charity and self-development.By fo...
|
|
